The U.S currently does not have any large-scale commercial production of the isotope Mo-99 used for nuclear imaging. It is critical to more 40,000 nuclear imaging exams each day, representing about 80% of all diagnostic molecular imaging procedures.  

"This can't drag on. Patients needing cancer treatment can’t wait two months for an accurate diagnosis.” 

The supply of Mo-99 and Tc-99m—the most commonly utilized medical isotopes in the world—could be cut by as much as 40% until the reactor in the Netherlands is up and running again.

During an initial three-month intervention period, one health system estimates that its saved nearly 750,000 mL of contrast. Now, experts from the organization are sharing whether those changes stuck after the shortage ended.

Adjusting contrast dose based on a patient’s lean body weight provides the same image quality as other administration methods, new data show.

Interlune has received $15M in funding to develop a scalable supply of Helium-3 from the lunar surface.

Eckert & Ziegler and Nucleus RadioPharma have signed an agreement to address the increasing demand for Lu-177 and Ac-225.

The German manufacturer and Canadian drug developer are partnering to address the supply crunch of radioisotopes.